Dossenheim, Germany

Ralf Eckert

This inventor holds 1 USPTO granted patent. Top assignee: Leica Microsystems Nussloch Gmbh. Active years: 2004.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ralf Eckert: Innovator in Cytological and Histological Treatment Technologies

Introduction

Ralf Eckert is a notable inventor based in Dossenheim, Germany. He has made significant contributions to the field of cytology and histology through his innovative inventions. His work primarily focuses on developing advanced apparatuses for treating various specimens.

Latest Patents

Ralf Eckert holds a patent for an "Apparatus for treating objects." This apparatus is designed specifically for cytological or histological specimens and features multiple processing stations. It includes a transport device that facilitates the delivery of objects into and out of these processing stations. A key characteristic of this invention is the inclusion of at least one heatable reagent station as a processing station. He has 1 patent to his name.

Career Highlights

Eckert is currently employed at Leica Microsystems Nussloch GmbH, a company renowned for its cutting-edge optical and imaging technologies. His role at the company allows him to further develop his innovative ideas and contribute to advancements in the field.

Collaborations

Throughout his career, Ralf has collaborated with talented individuals such as Charilaos Dalkidis and Stefan Kuenkel. These collaborations have likely enriched his work and led to further innovations in his field.

Conclusion

Ralf Eckert is a distinguished inventor whose work in developing apparatuses for treating cytological and histological specimens has made a significant impact. His contributions continue to advance the field and inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…